Successful Desensitization to Oxaliplatin After a Single Initial Dose of Omalizumab in a Patient With Elevated IgE Levels

J Investig Allergol Clin Immunol. 2020;30(4):293-295. doi: 10.18176/jiaci.0496. Epub 2020 Feb 25.

Authors

J Penella¹, P Quan¹, A Carvallo¹, A Chopitea², P Sala², M A García Del Barrio³, G Gastaminza¹, M J Goikoetxea¹

Affiliations

¹ Department of Allergy and Clinical Immunology, Clínica Universidad de Navarra, Pamplona, Spain.
² Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain.
³ Department of Pharmacy, Clínica Universidad de Navarra, Pamplona, Spain.

PMID: 32101174
DOI: 10.18176/jiaci.0496

No abstract available

Keywords: Desensitization; Drug allergy; Omalizumab; Oxaliplatin.

Publication types

Case Reports

MeSH terms

Adenocarcinoma / drug therapy*
Allergens / adverse effects
Allergens / immunology
Antineoplastic Agents / adverse effects
Antineoplastic Agents / therapeutic use*
Colonic Neoplasms / drug therapy*
Desensitization, Immunologic / methods*
Drug Hypersensitivity / diagnosis*
Erythema
Humans
Immunoglobulin E / blood
Male
Middle Aged
Omalizumab / therapeutic use*
Oxaliplatin / adverse effects
Oxaliplatin / therapeutic use*
Skin Tests
Up-Regulation

Substances

Allergens
Antineoplastic Agents
Oxaliplatin
Omalizumab
Immunoglobulin E